Retroperitoneal fibrosis and membranous nephropathy. Improvement of both diseases after treatment with steroids and immunosuppressive agents

Nephrology Dialysis Transplantation

Volumn 14, Issue 5, 1999, Pages 1303-1305

  Moroni, Gabriella ^a   Farricciotti, Alessio ^a   Cappelletti, Marco ^a   Ponticelli, Claudio ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Chronic periaortitis; Immunosuppressive therapy; Membranous nephropathy; Nephrotic syndrome; Retroperitoneal fibrosis

Indexed keywords

CHLORAMBUCIL; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RETROPERITONEAL FIBROSIS;

ANTI-INFLAMMATORY AGENTS; CHLORAMBUCIL; DRUG THERAPY, COMBINATION; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PREDNISONE; RETROPERITONEAL FIBROSIS;

EID: 0032892754     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.5.1303     Document Type: Article

References (16)

1. Parum DV. The spectrum of chronic periaortitis. Histopathology 1990; 16: 423-431
2. Mitchinson MJ. Retroperitoneal fibrosis revisited. Arch Pathol Lab Med 1986; 110: 784-786
3. Parum DV, Chadwick DR, Mitchinson MJ. The localization of immunoglobulin in chronic periaortitis. Atherosclerosis 1986; 6: 117-123
4. Parum DV, Brown DL, Mitchinson MJ. Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis. Arch Pathol Lab Med 1990; 114: 383-387
5. Lichon FS, Sequeira HV, Pilloff A, Skosey JL. Retroperitoneal fibrosis associated with systemic lupus erythematosus: A case report and brief review. J Rheumatol 1984; 11: 373-374
6. Hollingworth P, Denman AM, Gumpel JM. Retroperitoneal fibrosis and polyarteritis nodosa successfully treated by intensive immunosuppression. J R Soc Med 1980; 73: 61-64
7. Baker LR, Mallinson WJ, Gregory MC et al. Idiopathic retroperitoneal fibrosis. A retrospective analysis of 60 cases. Br J Urol 1988; 60: 497-503
8. Lipman RL, Johnson B, Berg G, Shapiro AP. Idiopathic retroperitoneal fibrosis and probable systemic lupus erythematosus. JAMA 1966; 196: 1022-1024
9. Katz SM, Bates O, Yudis M, Falkner B, Griffith E. Immune complex glomerulonephritis in a case of retroperitoneal fibrosis. Am J Clin Path 1977; 67: 436-439
10. Zabetakis PM, Novich RK, Matarese RA, Michelis MF. Idiopathic retroperitoneal fibrosis: a systemic connective tissue disease? J Urol 1979; 122: 100-102
11. Ponticelli C, Zucchelli P, Imbasciati E et al. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 1984; 310: 946-950
12. Kerjaschki D. Molecular pathogenesis of membranous nephropathy. Kidney Int 1992; 41: 1090-1105
13. Gilkenson GS, Allen NB. Retroperitoneal fibrosis. A true connective tissue disease. Rheum Dis Clin North Am 1996; 22: 23-39
14. McDouglas WS, MacDonell RC. Treatment of idiopathic retroperitoneal fibrosis by immunosuppression. J Urol 1991; 145: 112-114
15. Cogan E, Fastrez R. Azathioprine. An alternative treatment for recurrent idiopathic retroperitoneal fibrosis. Arch Intern Med 1985; 145: 753-755
16. Ponticelli C, Zucchelli P, Passerini P et al. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 1995; 48: 1600-1604